Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2000
10/24/2000US6136569 Accurate method for identifying genes encoding secreted and membrane-bound proteins using a starch degrading enzyme as a reporter molecule
10/24/2000US6136568 De novo polynucleotide synthesis using rolling templates
10/24/2000US6136567 Production of proteins, plasmids coding therefor and organisms containing such plasmids
10/24/2000US6136566 Collection of cultured eukaryotic cells; for screening for mutations in specific genes and for gathering nucleotide sequence data from each mutated gene to provide a database of tagged gene sequences
10/24/2000US6136565 Methods of reducing the levels of protoporphyrin IX in recombinant hemoglobin preparations
10/24/2000US6136564 Process for the production of peptides by way of streptavidin fusion proteins
10/24/2000US6136563 With defined substitutions for enhanced affinity for its receptor
10/24/2000US6136562 Synthetic dna which encodes a peptide having a defined amino acid sequence; for recombinant production of the peptide for use in cattle; veterinary medicine
10/24/2000US6136560 Amidotransferase, ratB, of streptococcus pneumoniae
10/24/2000US6136559 DNA encoding as human histamine receptor of the H3 subtype
10/24/2000US6136557 Strepococcus pneumoniae gene sequence FtsH
10/24/2000US6136556 TCTS response regulator
10/24/2000US6136555 Purification method and apparatus
10/24/2000US6136553 Computer based method for identifying amino acid sites which affect stability of the target protein
10/24/2000US6136550 Dna which encodes the amino acid sequence of an alpha5 receptor; for drug screening of agonists and antagonists
10/24/2000US6136544 Amino acid sequence of unedited form of human excitatory amino acid 4 receptor subunit; for drug screening
10/24/2000US6136538 Silent inducible virus replicons and uses thereof
10/24/2000US6136536 Recombinant dna sequence from plasmid phtop; for production in chinese hamster ovary cell lines
10/24/2000US6136534 Methods for sensitive detection of reverse transcriptase
10/24/2000US6136532 Methods for treating bipolar mood disorder associated with markers on chromosome 18q
10/24/2000US6136529 Nucleic acid probes to Mycobacterium avium complex
10/24/2000US6136528 Multiple sclerosis virus
10/24/2000US6136527 Polypeptides derived from proteins of the hepatitis C virus, test kits containing these polypeptides and vaccines against infections of hepatitis C viruses
10/24/2000US6136526 Use of human neutrophil lipocalin (HNL) as a diagnostic marker and anti-HNL-antibody preparation
10/24/2000US6136324 Deactivating tuberculosis gene
10/24/2000US6136322 Genetic engineering
10/24/2000US6136320 Orally acceptable immunogenic composition
10/24/2000US6136318 Genetic engineering
10/24/2000US6136310 Recombinant anti-CD4 antibodies for human therapy
10/24/2000US6136309 Antibodies against the interferon (IFN) α/β receptor (IFNAR2) that preferentially block the activity of IFN-α
10/24/2000US6136307 Reovirus for the treatment of cellular proliferative disorders
10/24/2000US6136269 Combinatorial kit for polymer synthesis
10/24/2000US6136040 Animal model with disrupted FGF-9 gene
10/24/2000US6135942 Nucleotide sequences of a drosophilia melanogaster insulin-like gene, the amino acid sequences of the encoded protein, and derivatives, e.g., fragments, and analogs; identifying modified genes; participate in signal transduction
10/24/2000CA2220873C Method for reproducing in vitro the rna-dependent rna polymerase and terminal nucleotidyl transferase activities encoded by hepatitis c virus (hcv)
10/24/2000CA2147541C Preparation process of a natural protein sweetener
10/24/2000CA2113106C Fluorescent microparticles with controllable enhanced stokes shift
10/24/2000CA2065439C Expression of herbicide metobolizing cytochromes p450
10/24/2000CA2061569C Improved activation of recombinant proteins
10/24/2000CA2047702C Serpin resistant chymotrypsin superfamily proteases particularly pai-1 resistant t-pa, complementary inhibitor mutants; compositions; genes; expression
10/24/2000CA1341124C Genetic engineering process for the preparation of hirudins, and means for carrying out this process
10/21/2000CA2268379A1 Inhibitor ligands directed against a receptor of vascular endothelial growth factor or against its coding sequence, as anti-angiogenics
10/20/2000CA2306355A1 Methods and compositions for treating human cells
10/20/2000CA2271451A1 Variant c-terminal fragment of plasmodium falciparum msp-1
10/19/2000WO2000062071A1 Diagnostic and therapeutic use of antibodies against the urokinase receptor
10/19/2000WO2000062067A1 Novel transduction molecules and methods for using same
10/19/2000WO2000062023A1 Fta-coated media for use as a molecular diagnostic tool
10/19/2000WO2000061822A1 Compositions and methods for removing pollutants from contaminated materials
10/19/2000WO2000061816A1 Electronically mediated nucleic acid amplification in nasba
10/19/2000WO2000061815A1 In vitro ribosome evolution
10/19/2000WO2000061814A1 Detection of chromosome copy number changes to distinguish melanocytic nevi from malignant melanoma
10/19/2000WO2000061813A1 A second mammalian tankyrase
10/19/2000WO2000061810A1 Antisense oligonucleotides comprising universal and/or degenerate bases
10/19/2000WO2000061809A2 Methods and nucleic acid vectors for rapid and parallel assay development, for characterization of biological response modifiers
10/19/2000WO2000061808A2 Methods for detecting nucleic acids indicative of cancer
10/19/2000WO2000061807A1 Amplification and sequencing primer pairs and use thereof
10/19/2000WO2000061805A1 Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip
10/19/2000WO2000061804A1 Tissue-specific and pathogen-specific toxic agents and ribozymes
10/19/2000WO2000061798A2 Method for mapping a dna molecule comprising an ad infinitum amplification step
10/19/2000WO2000061793A2 Novel method for identifying antibacterial compounds
10/19/2000WO2000061792A1 Novel essential bacterial genes and their proteins
10/19/2000WO2000061786A2 Antisense modulation of pdk-1 expression
10/19/2000WO2000061781A1 Cyclic gmp dependent protein kinase as a chemotherapeutic target for antiprotozoal agents
10/19/2000WO2000061779A1 49 human secreted proteins
10/19/2000WO2000061775A1 Synthesis of biologically active compounds in cells
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061773A1 Recombinant and mutant adenoviruses derived of bovine adenovirus type 1
10/19/2000WO2000061772A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
10/19/2000WO2000061771A2 Transgenic plants containing altered levels of sterol compounds and tocopherols
10/19/2000WO2000061770A2 Enhancement of the immune response for vaccine and gene therapy applications
10/19/2000WO2000061769A1 ALKALINE PROTEASE VapK SUITABLE FOR LAUNDRY DETERGENT, vapk GENE, RECOMBINANT EXPRESSION VECTOR, AND TRANSFORMED MICROORGANISMS
10/19/2000WO2000061768A2 Preparation of biologically active molecules
10/19/2000WO2000061767A1 Extracellular protease from $i(acremonium chrysogenum) with cpc-acetyl hydrolase activity and its utilization in the synthesis of deacetylated derivatives of cephalosporin c and inactivation of the gene for increasing production of cephalosporin
10/19/2000WO2000061766A2 Telomerase-specific cancer vaccine
10/19/2000WO2000061765A2 Lipoxygenase proteins and polynucleotides encoding the same
10/19/2000WO2000061764A1 Carotene hydroxylase and method for producing xanthophyll derivatives
10/19/2000WO2000061763A2 Proteins related to gaba metabolism
10/19/2000WO2000061762A1 RECOMBINANT TOXIN A/TOXIN B VACCINE AGAINST $i(CLOSTRIDIUM DIFFICILE)
10/19/2000WO2000061761A2 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
10/19/2000WO2000061760A1 Piromyces equi carbohydrate binding domains
10/19/2000WO2000061759A1 Protein sweetener
10/19/2000WO2000061758A1 Viral variants
10/19/2000WO2000061757A1 Tumor necrosis factor homologs and nucleic acids encoding the same
10/19/2000WO2000061756A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
10/19/2000WO2000061755A2 Secreted human proteins
10/19/2000WO2000061754A2 Human proteins and polynucleotides encoding them
10/19/2000WO2000061753A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/19/2000WO2000061752A2 Modified complement system regulators
10/19/2000WO2000061751A1 REAGENTS AND METHODS FOR IDENTIFYING AND MODULATING EXPRESSION OF GENES REGULATED BY p21
10/19/2000WO2000061750A2 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
10/19/2000WO2000061749A1 Cellular protein p60 that interacts with herpesvirus regulatory proteins
10/19/2000WO2000061748A1 48 human secreted proteins
10/19/2000WO2000061747A2 Clasp-2 transmembrane proteins
10/19/2000WO2000061746A1 13 transmembrane protein expressed in prostate cancer
10/19/2000WO2000061745A1 Method for screening g protein-coupled receptor ligand and method for expression cloning g protein-coupled receptor
10/19/2000WO2000061744A1 Novel fetal genes
10/19/2000WO2000061743A1 Apoptosis-associated gene
10/19/2000WO2000061742A2 Treatment of cardiac power failure using s100 proteins
10/19/2000WO2000061741A1 Pcr-based cloning method
10/19/2000WO2000061740A1 Modified lipid production
1 ... 3167 3168 3169 3170 3171 3172 3173 3174 3175 3176 3177 3178 3179 3180 3181 3182 3183 3184 3185 3186 3187 ... 4023